tazarotene has been researched along with Juvenile Sulfatidosis in 1 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schlotawa, L | 1 |
| Tyka, K | 1 |
| Kettwig, M | 1 |
| Ahrens-Nicklas, RC | 1 |
| Baud, M | 1 |
| Berulava, T | 1 |
| Brunetti-Pierri, N | 1 |
| Gagne, A | 1 |
| Herbst, ZM | 1 |
| Maguire, JA | 1 |
| Monfregola, J | 1 |
| Pena, T | 1 |
| Radhakrishnan, K | 1 |
| Schröder, S | 1 |
| Waxman, EA | 1 |
| Ballabio, A | 1 |
| Dierks, T | 1 |
| Fischer, A | 1 |
| French, DL | 1 |
| Gelb, MH | 1 |
| Gärtner, J | 1 |
1 other study available for tazarotene and Juvenile Sulfatidosis
| Article | Year |
|---|---|
Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency.
Topics: Bexarotene; Drug Evaluation, Preclinical; Humans; Multiple Sulfatase Deficiency Disease; Oxidoreduct | 2023 |